☰

Ruiyang Zhao, Ph.D. - Publications

Affiliations: 
2008 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Molecular Biology, Genetics, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Deng H, Gao J, Cao B, Qiu Z, Li T, Zhao R, Li H, Wei B. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cellular Oncology (Dordrecht). PMID 37354353 DOI: 10.1007/s13402-023-00835-4  0.3
2023 Cao B, Zhao R, Li H, Xu X, Gao J, Chen L, Wei B. Inhibition of androgen receptor enhanced the anticancer effects of everolimus through targeting glucose transporter 12. International Journal of Biological Sciences. 19: 104-119. PMID 36594084 DOI: 10.7150/ijbs.75106  0.355
2022 Li H, Cao B, Zhao R, Li T, Xu X, Cui H, Deng H, Gao J, Wei B. circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis. Frontiers in Oncology. 12: 817192. PMID 35712504 DOI: 10.3389/fonc.2022.817192  0.324
2021 Wang Y, Cao B, Zhao R, Li H, Wei B, Dai G. Knockdown of circBFAR inhibits proliferation and glycolysis in gastric cancer by sponging miR-513a-3p/hexokinase 2 axis. Biochemical and Biophysical Research Communications. 560: 80-86. PMID 33979737 DOI: 10.1016/j.bbrc.2021.04.131  0.303
2016 Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. Ebiomedicine. 8: 30-39. PMID 27428416 DOI: 10.1016/j.ebiom.2016.04.017  0.7
2014 Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nature Communications. 5: 5384. PMID 25395170 DOI: 10.1038/ncomms6384  0.631
2014 Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, et al. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. Journal of the National Cancer Institute. 106. PMID 24957076 DOI: 10.1093/Jnci/Dju158  0.644
2013 Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle (Georgetown, Tex.). 12: 935-43. PMID 23421998 DOI: 10.4161/cc.23883  0.75
2012 Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, et al. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle (Georgetown, Tex.). 11: 4633-41. PMID 23187808 DOI: 10.4161/cc.22887  0.726
2012 Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, Yang H, Santiago J, Liu M, Yeung GE, Yeung SC, Lee MH. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle (Georgetown, Tex.). 11: 4181-90. PMID 23095642 DOI: 10.4161/cc.22413  0.769
2012 Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH, Yang H. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle (Georgetown, Tex.). 11: 785-96. PMID 22374676 DOI: 10.4161/cc.11.4.19228  0.564
2011 Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle (Georgetown, Tex.). 10: 3057-66. PMID 21876386 DOI: 10.4161/cc.10.18.17320  0.671
2011 Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC, Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene. 30: 4791-801. PMID 21625211 DOI: 10.1038/Onc.2011.192  0.736
2011 Zhao R, Fuentes-Mattei E, Velazquez-Torres G, Su CH, Chen J, Lee MH, Yeung SC. Exenatide improves glucocorticoid-induced glucose intolerance in mice. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 4: 61-5. PMID 21448323 DOI: 10.2147/DMSO.S15510  0.527
2011 Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. The Journal of Clinical Investigation. 121: 851-65. PMID 21317535 DOI: 10.1172/Jci44111  0.726
2011 Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Research. 71: 884-94. PMID 21135113 DOI: 10.1158/0008-5472.CAN-10-2518  0.74
2010 Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, Lee MH. Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Molecular Cancer. 9: 243. PMID 20843328 DOI: 10.1186/1476-4598-9-243  0.672
2009 Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. The American Journal of Pathology. 175: 400-11. PMID 19528349 DOI: 10.2353/ajpath.2009.080972  0.675
2009 Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Yeung SC, Lee MH. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene. 28: 2581-92. PMID 19483729 DOI: 10.1038/onc.2009.124  0.641
2008 Pan J, Chen B, Su CH, Zhao R, Xu ZX, Sun L, Lee MH, Yeung SC. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biology & Therapy. 7: 1679-84. PMID 18769123  0.669
2006 Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Research. 66: 3096-105. PMID 16540659 DOI: 10.1158/0008-5472.Can-05-3620  0.751
2006 Yang H, Zhang Y, Zhao R, Wen YY, Fournier K, Wu HB, Yang HY, Diaz J, Laronga C, Lee MH. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt. Oncogene. 25: 4585-94. PMID 16532026 DOI: 10.1038/Sj.Onc.1209481  0.755
2006 Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Molecular Cancer Therapeutics. 5: 253-60. PMID 16505098 DOI: 10.1158/1535-7163.MCT-05-0395  0.742
2006 Yang HY, Yang H, Zhao R, Lee MH. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity. Journal of Cellular Biochemistry. 98: 128-38. PMID 16365885 DOI: 10.1002/jcb.20762  0.747
2005 Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene. 24: 1924-35. PMID 15688030 DOI: 10.1038/sj.onc.1208352  0.775
Show low-probability matches.